Literature DB >> 2394621

Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia.

J R Gray1, K E Wallner.   

Abstract

Twenty patients with leukemic (8) or lymphomatous (12) meningitis and cranial nerve palsies were treated with cranial irradiation at Memorial Sloan-Kettering Cancer Center from June 1987 through December 1988. The diagnosis of malignant meningitis was confirmed by malignant or 'suspicious' cerebrospinal fluid cytology in 13/20 patients. The 6th and 7th cranial nerves were most commonly involved. Multiple nerve involvement was present in 11/20 patients, for a total of 42 nerves affected. Treatment consisted of whole brain irradiation to a median dose of 2400 cGy (range: 1000-3000) at 200-300 cGy per fraction. Median survival was 7 months. Forty of 42 nerves improved, for an actuarial response rate of 95% at 3 months. The complete response rate was 44% and was better for patients with lymphoma than for those with leukemia (72% vs 19%, p = 0.04). Delaying initiation of irradiation more than 3 days after the onset of symptoms did not affect the ultimate response rate, but slightly increased the median time to response (9 days vs 14 days, p = 0.1). Radiation therapy is an effective means of reversing cranial nerve dysfunction in leukemia and lymphoma. Higher doses may be needed to increase the rate of complete response.

Entities:  

Mesh:

Year:  1990        PMID: 2394621     DOI: 10.1016/0360-3016(90)90555-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

Review 1.  Metastatic neurologic complications of non-Hodgkin's lymphoma.

Authors:  Jeanine Grier; Tracy Batchelor
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

2.  Bilateral Facial Nerve Palsy in Acute B Cell Lymphoblastic Leukemia: A Case Report and Review of the Literature.

Authors:  Shiraj Sen; Arjun Gupta; Paul Friedman; Harris V Naina
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-02       Impact factor: 0.900

3.  Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature.

Authors:  Rita Assi; Lana Hamieh; Deborah Mukherji; Ali Haydar; Sally Temraz; Imane El-Dika; Ali Shamseddine
Journal:  J Gastrointest Oncol       Date:  2015-12

4.  Acute sciatica: an unusual presentation of extramedullary relapse of acute lymphoblastic leukemia.

Authors:  Hao-Chuan Liu; Giun-Yi Hung; Hsiu-Ju Yen; Ming-Yun Hsieh; Tzeon-Jye Chiou
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 5.  Current diagnosis and treatment of leptomeningeal metastasis.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

6.  Comprehensive craniospinal radiation for controlling central nervous system leukemia.

Authors:  Gary V Walker; Ferial Shihadeh; Hagop Kantarjian; Pamela Allen; Gabriela Rondon; Partow Kebriaei; Susan O'Brien; Aziza Kedir; Mustefa Said; Jonathan D Grant; Deborah A Thomas; Paul W Gidley; Isidora Arzu; Chelsea Pinnix; Valerie Reed; Bouthaina S Dabaja
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-01       Impact factor: 7.038

7.  Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.

Authors:  Jillian R Gunther; Ahmad R Rahman; Wenli Dong; Zeinab Abou Yehia; Partow Kebriaei; Gabriela Rondon; Chelsea C Pinnix; Sarah A Milgrom; Pamela K Allen; Bouthaina S Dabaja; Grace L Smith
Journal:  Pract Radiat Oncol       Date:  2017-05-10

8.  Emergent Radiotherapy for Leukemia-Induced Cranial Neuropathies Refractory to Intrathecal Therapy.

Authors:  Nirav Patel; Benjamin J RIch; Shareen Patel; Justin M Watts; Ronald Benveniste; Matthew Abramowitz; Arnold Markoe; Daniel G Eichberg; Ricardo J Komotar; Marcarena De La Fuente; Joshua Pasol; Tejan Diwanji
Journal:  Cureus       Date:  2021-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.